News Center
Zhangjiagang Taiwan Affairs Office, carrying out the activity “Thousands of Villages, Enterprises, and Families”, visited Jiangsu Lekai to conduct research and surveys.
2023-11-20
A few days ago, Zhang Yaoqing, director of the Zhangjiagang Taiwan Affairs Office, led a team to visit and conduct research on Taiwan-funded enterprises, incorporating the requirements of the ongoing second batch of theme education and the large-scale outreach program “Thousands of Villages, Enterprises, and Families”. They delved into the front lines of these enterprises to inquire about their situations, listen to their concerns and aspirations, and promote their development.

Founded in 2020, Jiangsu Lekai Biotechnology Co., Ltd. specializes in the production and operation of medical devices, with a registered capital of USD30 million. As a pioneer in the domestic medical bone cement industry, the company faces a promising market prospect and continues to intensify its investment. The phase II of the project is underway in full swing to speed up the construction. Director Zhang walked into the R&D workshop and the construction site of the phase II of the project, carefully inquired about team building, listened to the difficulties encountered by the company in meeting their needs, and encouraged them to strengthen exchanges and cooperation with universities and research institutes, attract and recruit talents, tackle hard-nut problems in science and technology, and strive for more breakthrough achievements.
During the visit, Zhang Yaoqing emphasized that as the “family member” of Taiwan-funded enterprises, the Taiwan Affairs Office should uphold the concept of “People on Both Sides of the Taiwan Strait as One Family,” effectively function as a “bridge”, precisely gather challenges faced by enterprises in operations and other aspects, actively coordinate with relevant functional departments, promptly address corporate concerns, assist in resolving practical issues, unceasingly enhance enterprise satisfaction, and better facilitate the in-depth development of Taiwan-funded enterprises.
A Brilliant Recap | Jiangsu Lekai Concludes with a Resounding Success at COA 2025!
2025-11-19
From November 12 to 16, 2025, the 24th Orthopaedic Academic Conference of the Chinese Medical Association and the 17th COA Academic Congress were grandly held at the Tianjin National Convention and Exhibition Center. Focusing on the theme "Intelligent Orthopaedics · Exploring Future Frontiers," the conference attracted tens of thousands of orthopaedic professionals from across the country to participate in this grand event.
Jiangsu Lekai "Collagen" obtained ISO 13485:2016 standard management system certification!
2025-02-13
Jiangsu Lekai Biotechnology Co., LTD. (hereinafter referred to as "Jiangsu Lekai") "collagen raw material" quality management system in accordance with: ISO 13485:2016 standard, obtained the management system certification certificate, certificate No. : C718165.
2024-12-25
Orthopedic colleagues from all over the country gathered in Wuhan to exchange scientific research, exchange techniques, explore and promote the innovation and transformation of the field of orthopedics in China.